Yongchun Yu Selected Research

Yongchun Yu Research Topics

Disease

32	Neoplasms (Cancer) 06/2023 - 01/2011
15	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 12/2014
11	Carcinogenesis 06/2023 - 12/2014
10	Liver Neoplasms (Liver Cancer) 01/2021 - 09/2013
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 06/2017
5	Lung Neoplasms (Lung Cancer) 01/2023 - 10/2018
5	Adenocarcinoma of Lung 12/2022 - 01/2021
4	Carcinoma (Carcinomatosis) 01/2021 - 10/2016
3	Esophageal Neoplasms (Esophageal Cancer) 06/2017 - 12/2013
2	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2018
2	Hypoxia (Hypoxemia) 06/2017 - 01/2017
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2023
1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Hyperthermia 08/2021
1	Gangrene 01/2021
1	Diabetes Mellitus 01/2021
1	Diabetic Foot 01/2021
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2021
1	Muscle Spasticity (Spastic) 09/2020
1	Paralysis (Palsy) 09/2020
1	Brain Neoplasms (Brain Tumor) 01/2020
1	Glioblastoma (Glioblastoma Multiforme) 01/2020
1	Hemorrhage 01/2018
1	Cardiomyopathies (Cardiomyopathy) 10/2017
1	Infections 08/2017
1	Urinary Bladder Neoplasms (Bladder Cancer) 06/2017

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 12/2022 - 02/2011
4	N-methyladenosineIBA 06/2023 - 01/2021
4	RNA (Ribonucleic Acid)IBA 06/2023 - 01/2020
4	6-methyladenineIBA 06/2023 - 01/2021
4	MicroRNAs (MicroRNA)IBA 01/2022 - 12/2013
4	Biomarkers (Surrogate Marker)IBA 12/2019 - 01/2015
3	CateninsIBA 06/2023 - 11/2013
3	Circular RNAIBA 01/2022 - 10/2018
3	huaierIBA 01/2020 - 01/2017
3	Tumor Biomarkers (Tumor Markers)IBA 06/2017 - 12/2014
2	bufalinIBA 01/2023 - 10/2018
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2017
2	corosolic acidIBA 01/2021 - 01/2017
2	AntioxidantsIBA 01/2021 - 01/2021
2	ChromatinIBA 01/2020 - 09/2013
2	Histones (Histone)IBA 01/2020 - 06/2017
2	PlatinumIBA 10/2018 - 12/2011
2	Sirtuin 1IBA 08/2017 - 03/2016
2	Long Noncoding RNAIBA 06/2017 - 12/2014
2	Transcription Factors (Transcription Factor)IBA 01/2017 - 12/2014
2	PhenanthrolinesIBA 10/2016 - 01/2016
2	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 01/2011
1	RNA-Binding Protein EWSIBA 06/2023
1	Small Nuclear RNA (snRNA)IBA 06/2023
1	Adenosine (Adenocard)FDA LinkGeneric 06/2023
1	erastinIBA 01/2023
1	Messenger RNA (mRNA)IBA 01/2023
1	Biocompatible Materials (Biomaterials)IBA 12/2022
1	F-Box ProteinsIBA 12/2022
1	Phosphopyruvate Hydratase (Enolase)IBA 01/2022
1	Lipid PeroxidesIBA 01/2022
1	Apolipoprotein E4IBA 01/2022
1	Circulating MicroRNAIBA 01/2022
1	IronIBA 01/2022
1	SiliconIBA 08/2021
1	Gefitinib (Iressa)FDA Link 01/2021
1	Glutamic Acid (Glutamate)FDA Link 01/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2021
1	NAD (NADH)IBA 01/2021
1	Cystine (L-Cystine)IBA 01/2021
1	Minichromosome Maintenance ProteinsIBA 01/2020
1	sanguinarineIBA 01/2020
1	LipidsIBA 01/2020
1	tanshinoneIBA 11/2019
1	Transforming Growth Factor beta (TGF-beta)IBA 11/2019
1	Lipid Bilayers (Lipid Bilayer)IBA 01/2019
1	atezolizumabIBA 10/2018
1	pembrolizumabIBA 10/2018
1	Anaplastic Lymphoma KinaseIBA 10/2018
1	NivolumabIBA 10/2018
1	Immune Checkpoint InhibitorsIBA 10/2018
1	AntibodiesIBA 10/2018
1	Immunoglobulin A (IgA)IBA 10/2018
1	B7-H1 AntigenIBA 10/2018
1	ErbB Receptors (EGF Receptor)IBA 10/2018
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2018
1	exodeoxyribonuclease IIBA 01/2018
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2018
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2018
1	Myosin Light Chains (Myosin Essential Light Chain)IBA 10/2017
1	C 31GIBA 10/2017
1	Staphylococcal Protein A (Protein A)IBA 09/2017
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 08/2017
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 06/2017
1	SirtuinsIBA 06/2017

Therapy/Procedure

8	Therapeutics 01/2022 - 08/2013
4	Drug Therapy (Chemotherapy) 08/2021 - 01/2017
1	Lasers (Laser) 01/2024
1	Precision Medicine 08/2021
1	Radiotherapy 08/2021
1	Surgical Amputation (Amputations) 01/2021
1	Heterologous Transplantation (Xenotransplantation) 01/2021
1	Denervation 09/2020
1	Immunotherapy 12/2019